Modeling melanoma-immune interactions with a physiological delay incorporating dendritic cell vaccines and anti-PD-1 therapy
{{output}}
Malignant melanoma is an aggressive skin cancer with limited responsiveness to traditional therapies. Notably, the combination of dendritic cell (DC) vaccines with anti-programmed cell death protein 1 (anti-PD-1) therapy has shown stronger clinical potential t... ...
